We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

135 hedge funds and large institutions have $327M invested in Definium Therapeutics in 2024 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 31 increasing their positions, 17 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,724% more capital invested

Capital invested by funds: $18M → $327M (+$310M)

364% more call options, than puts

Call options by funds: $28.4M | Put options by funds: $6.11M

300% more funds holding in top 10

Funds holding in top 10: 1 → 4 (+3)

254% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 13

82% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 17

72.01% more ownership

Funds ownership: 12.24% → 84.24% (+72%)

30% more funds holding

Funds holding: 104 → 135 (+31)

Holders
135
Holders Change
+31
Holders Change %
+29.81%
% of All Funds
1.94%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.06%
New
46
Increased
31
Reduced
17
Closed
13
Calls
$28.4M
Puts
$6.11M
Net Calls
+$22.3M
Net Calls Change
+$16.9M

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$38M
2
CC
Commodore Capital
New York
+$33.3M
3
DCM
Driehaus Capital Management
Illinois
+$14.5M
4
OCA
Octagon Capital Advisors
New York
+$12.3M
5
GPP
Great Point Partners
Connecticut
+$11.4M

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$1.72M
2
BB
Busey Bank
Illinois
-$572K
3
CAM
Cresset Asset Management
Illinois
-$565K
4
Group One Trading
Group One Trading
Illinois
-$422K
5
SC
Scotia Capital
Ontario, Canada
-$387K
Name Holding Trade Value Shares
Change 		Change in
Stake
S
101
SignatureFD
Georgia
$639 – – –
AF
102
Allworth Financial
California
$621 – – –
AF
103
Arrow Financial
New York
$620 – – –
HCM
104
Hollencrest Capital Management
California
$620 – – –
WIM
105
Westside Investment Management
California
$620 – – –
Toronto Dominion Bank
106
Toronto Dominion Bank
Ontario, Canada
$517 -$12K -2,102 -97%
TCM
107
Tradewinds Capital Management
Washington
$499 – – –
LI
108
Louisbourg Investments
New Brunswick, Canada
$492 – – –
PMFA
109
Plante Moran Financial Advisors
Michigan
$338 – – –
CAM
110
Chesapeake Asset Management
New York
$310 – – –
IA
111
IFP Advisors
Florida
$282 – – –
AAP
112
Arax Advisory Partners
Colorado
$264 – – –
RF
113
Robbins Farley
New Hampshire
$264 – – –
HWM
114
HighMark Wealth Management
Minnesota
$263 – – –
AWM
115
Avior Wealth Management
Nebraska
$225 -$34 -6 -20%
PP
116
Pacifica Partners
Canada
$208 – – –
SRCM
117
Signature Resources Capital Management
California
$194 – – –
CA
118
Continuum Advisory
Idaho
$182 +$114 +20 New
PA
119
Parallel Advisors
California
$179 -$2.61K -458 -96%
CP
120
Castleview Partners
Texas
$150 – – –
CA
121
CoreCap Advisors
Michigan
$141 +$86 +15 New
SIC
122
SJS Investment Consulting
Ohio
$113 -$11 -2 -14%
ACA
123
American Capital Advisory
Idaho
$105 – – –
CB
124
CNB Bank
Pennsylvania
$94 – – –
JWM
125
Janiczek Wealth Management
Colorado
$94 – – –
2 3 4
5
6

DFTX Hedge Fund Activity: Q1 2024 in Review

135 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q1 2024, worth a combined $327M — up 1,724% from $18M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new DFTX positions and 13 closed out — a net gain of 33 holders — while 31 added to existing stakes and 17 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $38M. The largest seller was Ikarian Capital, cutting an estimated $1.72M.

  • 135 institutional investors held Definium Therapeutics (DFTX) as of Q1 2024, up from 104 in Q4 2023.
  • Funds reported $327M of Definium Therapeutics stock for Q1 2024, up 1,724% quarter-over-quarter.
  • 46 funds opened new Definium Therapeutics positions in Q1 2024 and 13 closed out, a net change of +33 holders.
  • The largest Definium Therapeutics buyer in Q1 2024 was Deep Track Capital, an estimated $38M added.
  • The largest Definium Therapeutics seller in Q1 2024 was Ikarian Capital, an estimated $1.72M sold.

Based on aggregated 13F filings for Q1 2024.